• Facebook
  • +7 (499) 653-96-26
  • info@pharmaclon.ru

  • Events
  • RUS
  • Company
    • History
    • Documents
    • Partners
  • About the drug
    • About the drug
    • Instructions
    • Dosage scheme
    • Documents
  • Instructions
  • Clinical trials
  • Publications
  • Video
  • CONTACTS

Video


Tumor Necrosis Factor and Thymosin Alpha-1 is the combination of vital components in the treatment of tumors (oncology)



Events

Conference «BIOTEHMED» (Gelendzhik, Russia)

Date: 26.09-27.09.2016

More...

XXIII Congress of the European Association for Cranio Maxillo-Facial Surgery. London, United Kingdom

Date: 31.09-16.09.2016

More...

The study of REFNOT safety, tolerability and effectiveness.

Date: March 2005 г.

More...
...more events

 
Refnot-Pharm, LLC
123557, Moscow,
Presnenskiy val, 17
Commercial department:
Head of Department -
Nikita Romanovich Klyukin
Phone: +7 (499) 653-96-26
Email: info@refnot.ru
Clinical research department:
Phone: +7 (499) 579-84-88
Pharmacovigilance Department:
Head of Department -
Nadezhda Viktorovna Kashina.
Tel.: +7 (495) 120-12-47
Email: safety@refnot.ru
Menu
  • Company
  • About the drug
  • Instructions
  • Clinical trials
  • Publications
  • Video
  • Events
  • Contacts
Subscribe to our RSS feed
Like
on Facebook
Copyright © REFNOT 2023
Marketing Authorization of the Pharmaceutical Product №ЛС-001330 from 27.08.2010
There are contraindications. Consult medical prodessionals.
info@refnot.ru · +7 (495) 374-68-52 · REFNOT